One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Procept Biorobotics Corp before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Procept Biorobotics Corp’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Procept Biorobotics Corp’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Procept Biorobotics Corp (PRCT)

Before we jump into Procept Biorobotics Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Procept Biorobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). Its AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. It designs Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that are independent of prostate size and shape or surgeon experience.

Want to learn more about Procept Biorobotics Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Procept Biorobotics Corp. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Procept Biorobotics Corp’s Stock Price as of Market Close

As of March 23, 2023, 4:00 PM CST, Procept Biorobotics Corp’s stock price was $28.70.

Procept Biorobotics Corp is down 4.97% from its previous closing price of $30.20.

During the last market session, Procept Biorobotics Corp’s stock traded between $30.12 and $32.40. Currently, there are 44.64 million shares of Procept Biorobotics Corp stock available for purchase.

Unfortunately, Procept Biorobotics Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Procept Biorobotics Corp Stock Price History

Procept Biorobotics Corp’s (PRCT) price is currently down 23.36% so far this month.

During the month of March, Procept Biorobotics Corp’s stock price has reached a high of $38.07 and a low of $28.63.

Over the last year, Procept Biorobotics Corp has hit prices as high as $52.40 and as low as $28.88. Year to date, Procept Biorobotics Corp’s stock is up 14.75%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Procept Biorobotics Corp Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 22, 2023, there were 3 analysts who downgraded Procept Biorobotics Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Procept Biorobotics Corp’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Procept Biorobotics Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Procept Biorobotics Corp (PRCT) by visiting AAII Stock Evaluator.

Relative Price Strength of Procept Biorobotics Corp

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of March 22, 2023, Procept Biorobotics Corp has a weighted four-quarter relative price strength of -4.42%, which translates to a Momentum Score of 44 and is considered to be Average.

Want to learn more about how Procept Biorobotics Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Procept Biorobotics Corp Stock Price: Bottom Line

As of March 23, 2023, Procept Biorobotics Corp’s stock price is $28.70, which is down 4.97% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Procept Biorobotics Corp’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.